Mitsugu Kochi

机构：Nihon University · ORCID：0000-0003-2781-4947

发表论文 147 篇 · 总被引 1599 次 · h-index 20

代表论文

• Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial (2019 · Journal of Clinical Oncology · 被引 407)
• Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07 (2021 · Gastric Cancer · 被引 92)
• Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08 (2020 · British Journal of Cancer · 被引 48)
• A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer (2022 · Gastric Cancer · 被引 37)
• Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study (2023 · Gastric Cancer · 被引 27)
• Modified FOLFOXIRI plus cetuximab versus bevacizumab in RAS wild-type metastatic colorectal cancer: a randomized phase II DEEPER trial (2024 · Nature Communications · 被引 17)